GR270773

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GR270773, covering 2017-05-04 to 2017-05-04. Get the full timeline:

Most recent: Clinical Trial Update: GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults [Phase 2]